Why the study?
In ulcerative colitis, hsa_circ_0004104 may worsen inflammation and disrupt immune responses by affecting the JAK/STAT pathway and compromising epithelial barrier integrity.
Answers are grounded in this paper and cite their sources.
Elevated levels of hsa_circ_0004104 and JAK2 are associated with active ulcerative colitis, suggesting their potential utility as diagnostic biomarkers for disease activity.
Background Circular RNAs are stable non-coding RNAs that regulate biological processes via sponging microRNAs, interacting with RNA binding proteins, as well as controlling gene expression. In ulcerative colitis (UC), hsa_circ_0004104 may worsen inflammation and disrupt immune responses by affecting the JAK/STAT pathway and compromising epithelial barrier integrity. Subjects and methods The present study included 50 patients with UC and 25 healthy subjects as controls. The relative expression of hsa_circ_0004104 was analyzed using real-time quantitative polymerase chain reaction (qPCR), while the concentration of circulating Janus kinase 2 was determined using enzyme-linked immunosorbent assay (ELISA). Results hsa_circ_0004104 was significantly upregulated in active and inactive UC in contrast to control group. In addition, the active UC patients gave a significantly elevated JAK2 level in contrast to inactive and control groups. Furthermore, there was a potent positive correlation relating hsa_circ_0004104 to JAK2 expression in active UC patients. Conclusion Higher levels of hsa_circ_0004104 and JAK2 expression in active UC patients suggest their role in disease activity and their potential use as therapeutic targets and diagnostic biomarkers for UC management.
No takes yet. Share an insight, caveat, or question.
Elbannan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: